|Mr. Diggory William Howitt BE (Hons), MBA||CEO, MD, Pres & Exec. Director||3.16M||N/A||1967|
|Mr. Brent Andrew Cubis B.Com., C.A., BComm, CA||Chief Financial Officer||1.02M||N/A||N/A|
|Mr. Jan Janssen||Chief Technology Officer||1.39M||N/A||N/A|
|Mr. Richard Brook||Pres of EMEA & Latin American Region||1.69M||N/A||N/A|
|Mr. Anthony Manna||Pres of Americas Region||1.34M||N/A||N/A|
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories; and Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha soundarc, Baha 5 sound processor, Baha 5 power, Baha 5 superpower, other sound processors, and wireless accessories. It also provides Cochlear true wireless devices comprising mini microphones, phone clips, and TV streamers; and Cochlear Vistafix bone-anchored facial prosthetic solutions to enhance the attachment and cosmetic outcome of facial prostheses. The company has strategic collaboration with GN Hearing to develop integrated hearing solutions. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Cochlear Limited’s ISS Governance QualityScore as of December 8, 2019 is 9. The pillar scores are Audit: 9; Board: 8; Shareholder Rights: 6; Compensation: 3.